Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00425061 · ClinicalTrials.gov registry record · Phase 2
Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 159
- Enrollment target
NCT00425061 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 159 participants.
The verdict
NCT00425061, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 159 participants
- Enrollment target
Study Summary
Primary purpose is to assess if IMA-638 is safe and improves asthma in subjects with persistent asthma.
Interventions
- OTHER placebo
- BIOLOGICAL IMA-638
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00425061
The ClinicalTrials.gov registry entry for NCT00425061 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00425061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00425061 about?
NCT00425061 is a clinical study titled "Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma". Primary purpose is to assess if IMA-638 is safe and improves asthma in subjects with persistent asthma.
What is the current status of trial NCT00425061?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 159 participants. The study started on 2007-02. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00425061?
The interventions under investigation include: placebo (OTHER), IMA-638 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00425061?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.